Cervical carcinoma and human papillomavirus: On the road to preventing a major human cancer

Journal of the National Cancer Institute

Volumn 93, Issue 4, 2001, Pages 252-253

  zur Hausen, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STRUCTURAL PROTEIN; TRANSCRIPTION FACTOR AP 1; VIRUS PROTEIN; VIRUS VACCINE;

CASE CONTROL STUDY; COSTA RICA; DRUG SAFETY; EDITORIAL; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; NUCLEIC ACID BASE SUBSTITUTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS STRAIN; WART VIRUS;

EID: 0035925083     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.4.252     Document Type: Editorial

References (26)

1. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
2. Human papillomavirus type 16 variants and risk of cervical cancer
3. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
4. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy
5. INK4a as specific marker for dysplastic and neoplastic cells of the cervix uteri
6. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions
7. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
8. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex
9. Heritability of cervical tumours
10. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
11. Definition of linear antigenic regions of the HPV 16 L1 capsid protein using synthetic virion-like particles
12. HPV6b virus like particles are potent immunogens without adjuvant in man
13. Condylomata acuminata and human genital cancer
14. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer
15. Structure and transcription of human papillomavirus type 18 and 16 sequences in cervical carcinoma cells
16. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines
17. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence
18. Herpes simplex virus in human genital cancer
19. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA
20. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA
21. Characterization of primary human keratinocytes transformed by human papillomavirus type 18
22. Human papillomavirus infections in women with and without abnormal cervical cytology
23. Human papillomavirus and cervical neoplasia: A critical review of the epidemiological evidence
24. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Columbia and Spain
25. Risk factors for cervical cancer in Columbia and Spain
26. Estimates of worldwide incidence of 25 major cancers in 1990